Click for best price
Cancer Gene Therapy Market Size, Share 2023
| Market size in 2022 |
US$ 537.1 million
|
Forecast Market size by 2029 |
US$ 1617.3 million
|
| Growth Rate |
CAGR of 17.1% |
Number of Pages |
66 Pages |
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
This report aims to provide a comprehensive presentation of the global market for Cancer Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Gene Therapy. This report contains market size and forecasts of Cancer Gene Therapy in global, including the following market information:
Global Cancer Gene Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Gene Therapy market was valued at US$ 537.1 million in 2022 and is projected to reach US$ 1617.3 million by 2029, at a CAGR of 17.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Several unmet medical needs for treatment of cancer have encouraged R&D of cancer gene therapy. Various factors, such as increasing prevalence of cancer, rising government initiatives, increasing funding from various government and non-government organizations, are driving the global cancer gene therapy market. In addition, ethical acceptance of gene therapy for treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high cost involved in treatment are restraining the growth of global market for cancer gene therapy.
We has surveyed the Cancer Gene Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Gene Therapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Cancer Gene Therapy Market Segment Percentages, by Type, 2022 (%)
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy
Global Cancer Gene Therapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Cancer Gene Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Diagnostics Centers
Research Institutes
Global Cancer Gene Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Cancer Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Gene Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Gene Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Gene Therapy, market overview.
Chapter 2: Global Cancer Gene Therapy market size in revenue.
Chapter 3: Detailed analysis of Cancer Gene Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Gene Therapy Market, Global Outlook and Forecast 2023-2032 |
| Market size in 2022 |
US$ 537.1 million
|
| Forecast Market size by 2029 |
US$ 1617.3 million
|
| Growth Rate |
CAGR of 17.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Gene Therapy Overall Market Size
2.1 Global Cancer Gene Therapy Market Size: 2022 VS 2032
2.2 Global Cancer Gene Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Gene Therapy Players in Global Market
3.2 Top Global Cancer Gene Therapy Companies Ranked by Revenue
3.3 Global Cancer Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Gene Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Gene Therapy Market Size Markets, 2022 & 2032
4.1.2 Oncolytic Virotherapy
4.1.3 Gene Transfer
4.1.4 Gene-Induced Immunotherapy
4.2 By Type - Global Cancer Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Gene Therapy Revenue, 2018-2023
4.2.2 By Type - Global Cancer Gene Therapy Revenue, 2024-2032
4.2.3 By Type - Global Cancer Gene Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Gene Therapy Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Diagnostics Centers
5.1.4 Research Institutes
5.2 By Application - Global Cancer Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Gene Therapy Revenue, 2018-2023
5.2.2 By Application - Global Cancer Gene Therapy Revenue, 2024-2032
5.2.3 By Application - Global Cancer Gene Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Cancer Gene Therapy Market Size, 2022 & 2032
6.2 By Region - Global Cancer Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Gene Therapy Revenue, 2018-2023
6.2.2 By Region - Global Cancer Gene Therapy Revenue, 2024-2032
6.2.3 By Region - Global Cancer Gene Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Cancer Gene Therapy Revenue, 2018-2032
6.3.2 US Cancer Gene Therapy Market Size, 2018-2032
6.3.3 Canada Cancer Gene Therapy Market Size, 2018-2032
6.3.4 Mexico Cancer Gene Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Cancer Gene Therapy Revenue, 2018-2032
6.4.2 Germany Cancer Gene Therapy Market Size, 2018-2032
6.4.3 France Cancer Gene Therapy Market Size, 2018-2032
6.4.4 U.K. Cancer Gene Therapy Market Size, 2018-2032
6.4.5 Italy Cancer Gene Therapy Market Size, 2018-2032
6.4.6 Russia Cancer Gene Therapy Market Size, 2018-2032
6.4.7 Nordic Countries Cancer Gene Therapy Market Size, 2018-2032
6.4.8 Benelux Cancer Gene Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Cancer Gene Therapy Revenue, 2018-2032
6.5.2 China Cancer Gene Therapy Market Size, 2018-2032
6.5.3 Japan Cancer Gene Therapy Market Size, 2018-2032
6.5.4 South Korea Cancer Gene Therapy Market Size, 2018-2032
6.5.5 Southeast Asia Cancer Gene Therapy Market Size, 2018-2032
6.5.6 India Cancer Gene Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Cancer Gene Therapy Revenue, 2018-2032
6.6.2 Brazil Cancer Gene Therapy Market Size, 2018-2032
6.6.3 Argentina Cancer Gene Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Gene Therapy Revenue, 2018-2032
6.7.2 Turkey Cancer Gene Therapy Market Size, 2018-2032
6.7.3 Israel Cancer Gene Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia Cancer Gene Therapy Market Size, 2018-2032
6.7.5 UAE Cancer Gene Therapy Market Size, 2018-2032
7 Cancer Gene Therapy Companies Profiles
7.1 Adaptimmune
7.1.1 Adaptimmune Company Summary
7.1.2 Adaptimmune Business Overview
7.1.3 Adaptimmune Cancer Gene Therapy Major Product Offerings
7.1.4 Adaptimmune Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.1.5 Adaptimmune Key News & Latest Developments
7.2 Bluebird bio
7.2.1 Bluebird bio Company Summary
7.2.2 Bluebird bio Business Overview
7.2.3 Bluebird bio Cancer Gene Therapy Major Product Offerings
7.2.4 Bluebird bio Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.2.5 Bluebird bio Key News & Latest Developments
7.3 Celgene
7.3.1 Celgene Company Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Cancer Gene Therapy Major Product Offerings
7.3.4 Celgene Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.3.5 Celgene Key News & Latest Developments
7.4 Shanghai Sunway Biotech
7.4.1 Shanghai Sunway Biotech Company Summary
7.4.2 Shanghai Sunway Biotech Business Overview
7.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Major Product Offerings
7.4.4 Shanghai Sunway Biotech Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.4.5 Shanghai Sunway Biotech Key News & Latest Developments
7.5 Shenzhen SiBiono GeneTech
7.5.1 Shenzhen SiBiono GeneTech Company Summary
7.5.2 Shenzhen SiBiono GeneTech Business Overview
7.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Major Product Offerings
7.5.4 Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.5.5 Shenzhen SiBiono GeneTech Key News & Latest Developments
7.6 SynerGene Therapeutics
7.6.1 SynerGene Therapeutics Company Summary
7.6.2 SynerGene Therapeutics Business Overview
7.6.3 SynerGene Therapeutics Cancer Gene Therapy Major Product Offerings
7.6.4 SynerGene Therapeutics Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.6.5 SynerGene Therapeutics Key News & Latest Developments
7.7 Altor BioScience
7.7.1 Altor BioScience Company Summary
7.7.2 Altor BioScience Business Overview
7.7.3 Altor BioScience Cancer Gene Therapy Major Product Offerings
7.7.4 Altor BioScience Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.7.5 Altor BioScience Key News & Latest Developments
7.8 Amgen
7.8.1 Amgen Company Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Cancer Gene Therapy Major Product Offerings
7.8.4 Amgen Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.8.5 Amgen Key News & Latest Developments
7.9 Argenx
7.9.1 Argenx Company Summary
7.9.2 Argenx Business Overview
7.9.3 Argenx Cancer Gene Therapy Major Product Offerings
7.9.4 Argenx Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.9.5 Argenx Key News & Latest Developments
7.10 BioCancell
7.10.1 BioCancell Company Summary
7.10.2 BioCancell Business Overview
7.10.3 BioCancell Cancer Gene Therapy Major Product Offerings
7.10.4 BioCancell Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.10.5 BioCancell Key News & Latest Developments
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Company Summary
7.11.2 GlaxoSmithKline Business Overview
7.11.3 GlaxoSmithKline Cancer Gene Therapy Major Product Offerings
7.11.4 GlaxoSmithKline Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.11.5 GlaxoSmithKline Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Business Overview
7.12.3 Merck Cancer Gene Therapy Major Product Offerings
7.12.4 Merck Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.12.5 Merck Key News & Latest Developments
7.13 OncoGenex Pharmaceuticals
7.13.1 OncoGenex Pharmaceuticals Company Summary
7.13.2 OncoGenex Pharmaceuticals Business Overview
7.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Major Product Offerings
7.13.4 OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.13.5 OncoGenex Pharmaceuticals Key News & Latest Developments
7.14 Transgene
7.14.1 Transgene Company Summary
7.14.2 Transgene Business Overview
7.14.3 Transgene Cancer Gene Therapy Major Product Offerings
7.14.4 Transgene Cancer Gene Therapy Revenue in Global Market (2018-2023)
7.14.5 Transgene Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Gene Therapy Market Opportunities & Trends in Global Market
Table 2. Cancer Gene Therapy Market Drivers in Global Market
Table 3. Cancer Gene Therapy Market Restraints in Global Market
Table 4. Key Players of Cancer Gene Therapy in Global Market
Table 5. Top Cancer Gene Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Gene Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Gene Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Gene Therapy Product Type
Table 9. List of Global Tier 1 Cancer Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Gene Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Cancer Gene Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Gene Therapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Cancer Gene Therapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Cancer Gene Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Gene Therapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Cancer Gene Therapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Cancer Gene Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Gene Therapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Cancer Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Gene Therapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Cancer Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Gene Therapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Cancer Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Gene Therapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Cancer Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Gene Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Cancer Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Gene Therapy Revenue, (US$, Mn), 2024-2032
Table 30. Adaptimmune Company Summary
Table 31. Adaptimmune Cancer Gene Therapy Product Offerings
Table 32. Adaptimmune Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Adaptimmune Key News & Latest Developments
Table 34. Bluebird bio Company Summary
Table 35. Bluebird bio Cancer Gene Therapy Product Offerings
Table 36. Bluebird bio Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Bluebird bio Key News & Latest Developments
Table 38. Celgene Company Summary
Table 39. Celgene Cancer Gene Therapy Product Offerings
Table 40. Celgene Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Celgene Key News & Latest Developments
Table 42. Shanghai Sunway Biotech Company Summary
Table 43. Shanghai Sunway Biotech Cancer Gene Therapy Product Offerings
Table 44. Shanghai Sunway Biotech Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Shanghai Sunway Biotech Key News & Latest Developments
Table 46. Shenzhen SiBiono GeneTech Company Summary
Table 47. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Offerings
Table 48. Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Shenzhen SiBiono GeneTech Key News & Latest Developments
Table 50. SynerGene Therapeutics Company Summary
Table 51. SynerGene Therapeutics Cancer Gene Therapy Product Offerings
Table 52. SynerGene Therapeutics Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. SynerGene Therapeutics Key News & Latest Developments
Table 54. Altor BioScience Company Summary
Table 55. Altor BioScience Cancer Gene Therapy Product Offerings
Table 56. Altor BioScience Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Altor BioScience Key News & Latest Developments
Table 58. Amgen Company Summary
Table 59. Amgen Cancer Gene Therapy Product Offerings
Table 60. Amgen Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Amgen Key News & Latest Developments
Table 62. Argenx Company Summary
Table 63. Argenx Cancer Gene Therapy Product Offerings
Table 64. Argenx Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Argenx Key News & Latest Developments
Table 66. BioCancell Company Summary
Table 67. BioCancell Cancer Gene Therapy Product Offerings
Table 68. BioCancell Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. BioCancell Key News & Latest Developments
Table 70. GlaxoSmithKline Company Summary
Table 71. GlaxoSmithKline Cancer Gene Therapy Product Offerings
Table 72. GlaxoSmithKline Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. GlaxoSmithKline Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Cancer Gene Therapy Product Offerings
Table 76. Merck Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Merck Key News & Latest Developments
Table 78. OncoGenex Pharmaceuticals Company Summary
Table 79. OncoGenex Pharmaceuticals Cancer Gene Therapy Product Offerings
Table 80. OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. OncoGenex Pharmaceuticals Key News & Latest Developments
Table 82. Transgene Company Summary
Table 83. Transgene Cancer Gene Therapy Product Offerings
Table 84. Transgene Cancer Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Transgene Key News & Latest Developments
List of Figures
Figure 1. Cancer Gene Therapy Segment by Type in 2022
Figure 2. Cancer Gene Therapy Segment by Application in 2022
Figure 3. Global Cancer Gene Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Gene Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Cancer Gene Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2022
Figure 8. By Type - Global Cancer Gene Therapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global Cancer Gene Therapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global Cancer Gene Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Cancer Gene Therapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global Cancer Gene Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Cancer Gene Therapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global Cancer Gene Therapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America Cancer Gene Therapy Revenue Market Share, 2018-2032
Figure 16. US Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Cancer Gene Therapy Revenue Market Share, 2018-2032
Figure 20. Germany Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 21. France Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Cancer Gene Therapy Revenue Market Share, 2018-2032
Figure 28. China Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. India Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Cancer Gene Therapy Revenue Market Share, 2018-2032
Figure 34. Brazil Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Cancer Gene Therapy Revenue Market Share, 2018-2032
Figure 37. Turkey Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Cancer Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. Adaptimmune Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bluebird bio Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Celgene Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Shanghai Sunway Biotech Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. SynerGene Therapeutics Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Altor BioScience Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Amgen Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Argenx Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. BioCancell Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. GlaxoSmithKline Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Merck Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Transgene Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
